A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple Myeloma
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Relapsed Refractory Multiple Myeloma (RRMM)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Prince of Wales Hospital, Randwick, New South Wales, Australia
Illawarra Cancer care centre, Wollongong Hospital, Wollongong, New South Wales, Australia
Royal Adelaide Hospital, Adelaide, South Australia, Australia
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Alfred Hospital, Melbourne, Victoria, Australia
Study leads
Clinical Trial Management
Study Director
Regeneron Pharmaceuticals